We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$7.36B
AUM Growth
+$457M
Cap. Flow
-$178M
Cap. Flow %
-2.42%
Top 10 Hldgs %
26.1%
Holding
2,906
New
66
Increased
422
Reduced
1,573
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 25.69%
2 Consumer Discretionary 12.47%
3 Healthcare 12.1%
4 Financials 11.43%
5 Communication Services 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVGI icon
2776
Commercial Vehicle Group
CVGI
$130M
$8.03K ﹤0.01%
996
-3,579
-78% -$32.4K
CMCT
2777
Creative Media & Community Trust
CMCT
$14.7M
0
RVI
2778
DELISTED
Retail Value Inc. Common Shares
RVI
$7.33K ﹤0.01%
2,344
-64,766
-97% -$184K
FUV
2779
DELISTED
Arcimoto, Inc. Common Stock
FUV
$6.55K ﹤0.01%
42
-157
-79% -$32.1K
PARAA
2780
DELISTED
Paramount Global Class A
PARAA
$5.44K ﹤0.01%
163
+1
+0.6% +$37
EMKR
2781
DELISTED
Emcore Corp
EMKR
$4.37K ﹤0.01%
63
-332
-84% -$24.5K
PEI
2782
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$4.21K ﹤0.01%
275
-3
-1% -$64
APLT
2783
DELISTED
Applied Therapeutics
APLT
-5,405
Closed -$89.7K
ATER icon
2784
Aterian
ATER
$5.01M
-592
Closed -$77K
ATOS icon
2785
Atossa Therapeutics
ATOS
$24M
-1,031
Closed -$50.4K
BASE
2786
DELISTED
Couchbase
BASE
-3,054
Closed -$95K
BEEM icon
2787
Beam Global
BEEM
$25.8M
-2,420
Closed -$66.2K
BOLT icon
2788
Bolt Biotherapeutics
BOLT
$6.57M
-360
Closed -$91K
BYSI icon
2789
BeyondSpring
BYSI
$32.9M
-6,183
Closed -$97.4K
CLPT icon
2790
ClearPoint Neuro
CLPT
$464M
-5,911
Closed -$105K
CRDF icon
2791
Cardiff Oncology
CRDF
$79.4M
-11,065
Closed -$73.7K
CTSO icon
2792
Cytosorbents Corp
CTSO
$23.8M
-11,670
Closed -$94.8K
CURI icon
2793
CuriosityStream
CURI
$228M
-5,073
Closed -$53.5K
CURV icon
2794
Torrid Holdings
CURV
$226M
-4,356
Closed -$67.2K
DAWN
2795
DELISTED
Day One Biopharmaceuticals
DAWN
-3,636
Closed -$86.3K
DRRX
2796
DELISTED
DURECT Corp
DRRX
-3,215
Closed -$41.2K
DSGR icon
2797
Distribution Solutions Group
DSGR
$1.61B
-2,638
Closed -$66K
ELTX icon
2798
Elicio Therapeutics
ELTX
$81.4M
-742
Closed -$72.5K
EOLS icon
2799
Evolus
EOLS
$543M
-4,123
Closed -$31.4K
ERNA icon
2800
Eterna Therapeutics
ERNA
$5.12M
-1
Closed -$80.1K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 Portfolio in Review

As of Q4 2021, Metropolitan Life Insurance Company (MetLife) held 2,906 positions worth $7.36B, up 6.6% from $6.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 filing shows 66 new, 422 increased, 1,573 reduced and 124 closed positions. Its largest new stake was Kyndryl: 32,951 shares worth $596K. The largest sale was iShares Russell 1000 Growth ETF, an estimated $18.3M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2021 buy was Kyndryl: 32,951 shares worth $596K.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $34.8M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2021 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $18.3M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Kansas City Southern in Q4 2021, selling an estimated $3.18M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 26% of its $7.36B portfolio in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 66 new positions and closed 124 in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6.6% quarter-over-quarter to $7.36B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.